Results 241 to 250 of about 1,467,646 (404)

Characterization of free light chain impurity in a bispecific antibody. [PDF]

MAbs
Sadek M, Mantha N, Lippold S, Li D, Spitler K, Li R, Spinosa P, Liu B, Luu S, Woon N, Zhang Y, Guo J, Yang R, Zarzar J, Yang Y.   +14 more
europepmc   +1 more source

Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action [PDF]

, 2007
Zhengxing Qu, David M. Goldenberg, Thomas M. Cardillo, Victoria Shi, Hans J. Hansen, Chien‐Hsing Chang   +5 more
openalex   +1 more source

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

Cancer Immunology and Immunotherapy, 2020
Yan Wang, Haiqing Ni, Shuaixiang Zhou, K. He, Yarong Gao, Weiwei Wu, Min Wu, Zhihai Wu, X. Qiu, Ying Zhou, Bingliang Chen, D. Pan, Chenrong Huang, Mingzhu Li, Yicong Bian, Min Yang, L. Miao, Junjian Liu   +17 more
semanticscholar   +1 more source

Platforms for studying cell–cell recognition by immune cells

Immunology &Cell Biology, EarlyView.
This review compares different platforms for studying how immune cells integrate signals from co‐signaling receptor‐ligand interactions at cell–cell interfaces. By understanding the strengths and weaknesses of each platform, including which factors can be controlled by the user, immunologists can identify the most appropriate platform to address their ...
Jordan Kramer, P Anton van der Merwe, Omer Dushek   +2 more
wiley   +1 more source

Bispecific antibody for lung cancer: mechanisms and clinical insights. [PDF]

Front Immunol
Chen W, Zhou A, Zhou Y.
europepmc   +1 more source

Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin [PDF]

, 2007
Dafne Müller, Anette Karle, Bettina Meißburger, Ines Höfig, Roland Stork, Roland E. Kontermann   +5 more
openalex   +1 more source

Carcinoma of Esophagus

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Carcinoma of esophagus is one of the most common cancer worldwide, but its epidemiology is changing. Squamous cell carcinoma is declining in the East, but adenocarcinoma is rising in the West, probably related to the pandemic of obesity and changing lifestyle.
Joseph Sung, Dongxin Lin, Rebecca Fitzgerald, Prateek Sharma, Simon Law, David Ilson   +5 more
wiley   +1 more source

Bispecific antibody targeting shared indel-derived neoantigen of APC. [PDF]

Front Immunol
Effenberger C, Wu X, Zhao P, Matsumoto S, Nakamura Y, Kiyotani K.   +5 more
europepmc   +1 more source

Selective Targeting and Potent Control of Tumor Growth Using an EphA2/CD3-Bispecific Single-Chain Antibody Construct [PDF]

, 2007
Scott A. Hammond, Ralf Lutterbuese, Shannon Roff, Petra Lutterbuese, Bernd Schlereth, Elizabeth Bruckheimer, Michael S. Kinch, Steve Coats, Patrick A. Baeuerle, Peter Kufer, Peter A. Kiener   +10 more
openalex   +1 more source

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract The discovery of activating mutations in the epidermal growth factor receptor (EGFR) gene has revolutionized the management of lung cancer, enabling the development of targeted tyrosine kinase inhibitors (TKIs). These therapies offer improved survival and reduced side effects compared with conventional treatments.
Maxime Borgeaud, Timothée Olivier, Jair Bar, Stephanie Pei Li Saw, Kaushal Parikh, Giuseppe Luigi Banna, Claudio De Vito, Jill Feldman, Xiuning Le, Alfredo Addeo   +9 more
wiley   +1 more source